Delivery Order SPE2DE24DA017-SPE2D625F3LNM
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has been awarded a delivery order valued at $9,900 for the Arthrex ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment was issued on September 3, 2025, with an ultimate completion date of September 17, 2025. The award represents a non-set-aside competitive procurement and will be...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475.00 on May 16, 2025, for the ARTHREX ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 21, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The Medical Supply Chain, operating under the...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology leader, was awarded a $19.8K delivery order by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 8, 2025, and represents the final delivery location as Naples, FL. The award carries no set-aside designation, reflecting Arthrex's competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,665.20 for the Arthrex ACP Double Syringe System on April 24, 2025. This fixed-price contract with economic price adjustment carries an ultimate completion date of April 29, 2025, and will be performed in Naples, Florida. The award was issued by the Defense Logistics Agency's Medical Supply Chain to support the government's orthopedic medical device needs,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $7,177.50 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, calls for the delivery of system implementation quadrupel 9mm products and is scheduled for completion by August 15, 2025. This award was not set aside for any specific business...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $5,557.20 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. This fixed-price contract with economic price adjustment provisions is designated as a System Implementation Quadrilateral 9MM 1S and will be performed in Naples, Florida, with an ultimate completion date of August 21, 2025. The award is not set aside for any specific business...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $10,058.80 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for ultimate completion by August 15, 2025, and represents work to be performed at the company's Naples, Florida facility. The award was made without a set-aside designation,...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a fixed-price delivery order valued at $5,226.00 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the ARTHREX ACP DOUBLE 1S product. The contract, which is not set-aside, carries an ultimate completion date of September 17, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency valued at...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F3LNMDelivery Order
Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $8,250.00 for the Arthrex ACP Double Syringe System on September 15, 2025. This fixed-price delivery order with economic price adjustment is scheduled for ultimate completion on September 18, 2025, and will be performed at the company's Naples, FL facility. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency responsible for managing medical supply distribution to government healthcare systems. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running through September 1, 2029. The parent contract enables Veterans Affairs medical centers and Department of Defense facilities nationwide to procure Arthrex's comprehensive portfolio of orthopedic products, including surgical implants, arthroscopic instruments, and specialized surgical systems. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. To date, the company has received over $550,000 in delivery orders under this IDC, demonstrating sustained demand for its innovative orthopedic technologies across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 9/15/25 |